Dosimetry-Guided Radiopharmaceutical Therapy (DG-RPT)

Fighting Cancer.
Making it Personal.

WHY IT MATTERS

For cancer patients, personalized radiopharmaceutical therapy (RPT) can mean increased tumor response, a higher quality of life and longer overall survival.

The Advantages of Dosimetry-Guided RPT

RPT provides an attractive alternative to chemotherapy, but one-size-fits-all dosing methods can result in under- or over-treatment. Dosimetry-guidance can unlock the full potential of RPT for patients.

Maximum toxicity to tumors.

Reduced damage to critical structures.

Improved survival.

Fewer side effects.

Maximum toxicity to tumors.

Reduced damage to critical structures.

Improved survival.

Fewer side effects.

See How We're Improving RPT

Torch

GPU-Accelerated RPT Dose Assessment & Treatment Planning

Torch™ simplifies the otherwise complex task of analyzing a patient’s nuclear medicine scans to develop a personalized treatment plan that maximizes toxicity to tumors while limiting exposure to other organs. [1]

NEWS & WEBINARS

FDA approves Pluvicto for Prostate Cancer
The conversation cancer doesn’t want you to have
Voximetry awarded second advance matching grant from WEDC
The conversation cancer doesn’t want you to have